Jeffrey Rubnitz, M.D., Ph.D., St. Jude Children's Research Hospital (IMAGE)

St. Jude Children's Research Hospital

Jeffrey Rubnitz, M.D., Ph.D., St. Jude Children's Research Hospital

Caption

Jeffrey Rubnitz, M.D., Ph.D., of St. Jude Children's Research Hospital, led a study that suggests some pediatric AML patients may benefit from drugs designed to kill cells that carry a particular protein on their surface.

Credit

St. Jude Biomedical Communications

Usage Restrictions

Use image with appropriate caption and credits.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.